4//SEC Filing
Gottesdiener Andrew 4
Accession 0001104659-23-081731
CIK 0001974640other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 8:01 PM ET
Size
6.5 KB
Accession
0001104659-23-081731
Insider Transaction Report
Form 4
Gottesdiener Andrew
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-07-13+47,758→ 47,758 totalExercise: $17.00Exp: 2033-07-13→ Common Stock (47,758 underlying)
Footnotes (2)
- [F1]This option represents the right to purchase 47,758 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date.
- [F2]Under an agreement between the reporting person and VR Management, LLC (the "Management Company"), the reporting person is deemed to hold the reported option and the shares underlying the option for the sole benefit of the Management Company and must exercise the reported option solely upon the direction of the Management Company, which is entitled to the shares underlying the option. The Management Company may be deemed the indirect beneficial owner of the shares underlying the option, and the reporting person may be deemed the indirect beneficial owner of the reported shares underlying the option through his interest in the Management Company. The reporting person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Apogee Therapeutics, Inc.
CIK 0001974640
Entity typeother
Related Parties
1- filerCIK 0001972292
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 8:01 PM ET
- Size
- 6.5 KB